Natural Product: NPC470702

Natural Product IDNPC470702
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Spongotine A
IUPAC Name [5-(6-bromo-1H-indol-3-yl)-4,5-dihydro-1H-imidazol-2-yl]-(1H-indol-3-yl)methanone
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL219351
PubChem CID 14168300
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles
          • [CHEMONTID:0004196] 3-alkylindoles

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BYNAFSYAUGRDSZ-UHFFFAOYSA-N
Standard InCHI InChI=1S/C20H15BrN4O/c21-11-5-6-13-14(8-23-17(13)7-11)18-10-24-20(25-18)19(26)15-9-22-16-4-2-1-3-12(15)16/h1-9,18,22-23H,10H2,(H,24,25)
SMILES Brc1ccc2c(c1)[nH]cc2C1CNC(=N1)C(=O)c1c[nH]c2c1cccc2

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   406.04 Volume:   357.39
?
Van der Waals volume.
Dense:   1.136 LogP:   3.977
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.426
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.824
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   26.0
TPSA:   73.04
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   3.0 Rings:   5.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.442 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.441 Fsp3:   0.1
MCE-18:   79.545
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.982 Fluc inhibitor:   0.834
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.184
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.983
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.015 Promiscuous compounds:   0.454

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.962 MDCK Permeability:   -4.638
Pgp-inhibitor:   0.344 Pgp-substrate:   0.208
PAMPA:   0.427
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.0 30% Bioavailability (F30%):   0.073
50% Bioavailability (F50%):   0.293

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.764 MRP1:   0.693
Plasma Protein Binding (PPB):   91.624% Volume Distribution (VD):   0.454
Fu: 6.184%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.775
OATP1B3 inhibitor:   0.974 BCRP inhibitor:   0.004
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.005 CYP1A2-substrate:   0.037
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.428
CYP2C9-inhibitor:   0.003 CYP2C9-substrate:   0.016
CYP2D6-inhibitor:   0.037 CYP2D6-substrate:   0.408
CYP3A4-inhibitor:   0.04 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.626
HLM stability:   0.051
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.231 Half-life (T1/2):  0.855

ADMET: Toxicity

hERG Blockers:  0.315 hERG Blockers (10um):  0.629
Human Hepatotoxicity (H-HT):  0.819 Drug-induced Liver Injury (DILI):  0.86
AMES Toxicity:  0.403 Rat Oral Acute Toxicity:  0.808
Maximum Recommended Daily Dose:  0.939 Skin Sensitization:  0.627
Carcinogencity:  0.653 Eye Corrosion:  0.0
Eye Irritation:  0.351 Respiratory Toxicity:  0.667
Drug-induced Neurotoxicity:  0.909 Ototoxicity:  0.608
Hematotoxicity:  0.296 Drug-induced Nephrotoxicity:  0.459
Genotoxicity:  0.987 RPMI-8226 Immunitoxicity:  0.028
A549 Cytotoxicity:  0.107 Hek293 Cytotoxicity:  0.284
BCF:   1.898
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.512
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.945
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.533
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[15921415]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[16154746]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[17253840]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. southern australian n.a. PMID[9599272]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell line A549 Homo sapiens ED50 = 6.82 ug ml-1 PMID[17477518]
NPT146 Cell line SK-OV-3 Homo sapiens ED50 = 3.71 ug ml-1 PMID[17477518]
NPT147 Cell line SK-MEL-2 Homo sapiens ED50 = 5.04 ug ml-1 PMID[17477518]
NPT574 Cell line XF498 Homo sapiens ED50 = 7.22 ug ml-1 PMID[22348826]
NPT148 Cell line HCT-15 Homo sapiens ED50 = 9.8 ug ml-1 PMID[20966043]
NPT196 Cell line AGS Homo sapiens IC50 = 1.1 ug.mL-1 PMID[36170798]
NPT137 Cell line L1210 Mus musculus IC50 = 1.1 ug.mL-1 PMID[36170798]
NPT28438 Unchecked Unchecked n.a. IC50 = 16.0 nM PMID[32220687]
NPT28438 Unchecked Unchecked n.a. IC50 = 10.7 ug.mL-1 PMID[36170798]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC470702 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC611421
0.8833 High Similarity NPC470703
0.8833 High Similarity NPC223916
0.6 Remote Similarity NPC473218
0.5946 Remote Similarity NPC220797
0.5946 Remote Similarity NPC201266
0.5946 Remote Similarity NPC268744

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470702 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data